Chajek-Shaul T, Hayek T, Walsh A, Breslow J L
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, NY 10021-6399.
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6731-5. doi: 10.1073/pnas.88.15.6731.
Transgenic mice carrying the human apolipoprotein (apo) A-I gene (HuAITg mice) were used to examine the effects of overexpression of the human gene on high density lipoprotein (HDL) particle size distribution and metabolism. On a chow diet, control mice had HDL cholesterol and apo A-I levels of 49 +/- 2 and 137 +/- 12 mg/dl of plasma, respectively. HuAITg mice had HDL cholesterol, human apo A-I, and mouse apo A-I levels of 88 +/- 2, 255 +/- 19, and 16 +/- 2 mg/dl, respectively. Nondenaturing gradient gel electrophoresis revealed control mouse plasma HDL to be primarily monodisperse with a particle diameter of 10.2 nm, whereas HuAITg mouse plasma HDL was polydisperse with particles of diameter 11.4, 10.2, and 8.7 nm, which correspond in size to human HDL1, HDL2, and HDL3, respectively. In vivo turnover studies of HDL labeled with [3H]cholesteryl linoleyl ether (representing the cholesteryl ester pool) and 125I-apo A-I were performed. In control animals, the fractional catabolic rate (FCR) for HDL cholesteryl ester (0.197 +/- 0.010 pool/hr) was significantly (P less than 0.0005) more than the apo A-I FCR (0.118 +/- 0.006 pool/hr). In the HuAITg mice, the HDL cholesteryl ester FCR (0.124 +/- 0.008 pool/hr) was the same as the apo A-I FCR (0.126 +/- 0.010 pool/hr). There were no significant differences between control and HuAITg animals in the sites of tissue removal of HDL cholesteryl ester, with the liver extracting most of the injected radioactivity. Control and HuAITg animals had comparable liver and intestinal cholesterol synthesis and LDL FCR. In conclusion, HuAITg mice have principally human and not mouse apo A-I in their plasma. This apparently causes a change in HDL particle size distribution in the transgenic mice to one resembling the human pattern. The replacement of mouse by human apo A-I also apparently causes the loss of the selective uptake pathway of HDL cholesteryl esters present in control mice. These data imply that apo A-I primary structure has a profound influence on HDL particle size distribution and metabolism.
携带人类载脂蛋白(apo)A-I基因的转基因小鼠(HuAITg小鼠)被用于研究人类基因过表达对高密度脂蛋白(HDL)颗粒大小分布和代谢的影响。在普通饮食条件下,对照小鼠血浆中HDL胆固醇和apo A-I水平分别为49±2和137±12mg/dl。HuAITg小鼠的HDL胆固醇、人类apo A-I和小鼠apo A-I水平分别为88±2、255±19和16±2mg/dl。非变性梯度凝胶电泳显示,对照小鼠血浆HDL主要为单分散,颗粒直径为10.2nm,而HuAITg小鼠血浆HDL为多分散,颗粒直径分别为11.4、10.2和8.7nm,其大小分别对应于人类HDL1、HDL2和HDL3。对用[3H]胆固醇亚油酸醚(代表胆固醇酯池)和125I-apo A-I标记的HDL进行了体内周转研究。在对照动物中HDL胆固醇酯的分解代谢率(FCR)(0.197±0.010池/小时)显著(P<0.0005)高于apo A-I的FCR(0.118±0.006池/小时)。在HuAITg小鼠中,HDL胆固醇酯FCR(0.124±0.008池/小时)与apo A-I的FCR(0.126±0.010池/小时)相同。对照动物和HuAITg动物在HDL胆固醇酯的组织清除部位没有显著差异,肝脏摄取了大部分注入的放射性物质。对照动物和HuAITg动物的肝脏和肠道胆固醇合成以及LDL FCR相当。总之,HuAITg小鼠血浆中主要是人类而非小鼠的apo A-I。这显然导致转基因小鼠中HDL颗粒大小分布发生变化,使其类似于人类模式。用人类apo A-I替代小鼠apo A-I显然也导致对照小鼠中存在的HDL胆固醇酯选择性摄取途径丧失。这些数据表明apo A-I一级结构对HDL颗粒大小分布和代谢有深远影响。